NCT03509987

Brief Summary

The aim of the present study was to compare hemoglobin (Hb) levels determined by point of care testing HemaCue and arterial blood gas analyzer with an automated hematology analyzer in critically ill geriatric patients.Forty geriatric patients requiring intensive care treatment were included in the study. Arterial blood sample was analyzed using HemaCue (HbHemaCueArterial), blood gas analyzer (Techno Medica, Gastat1800 series) (HbBGA) and an automated hematology analyzer (Cell Dyne 3700 System, Abbot Laboratories)(HbLab) as a reference method. Capillary blood measurements were performed (HbHemaCueCapillary) by HemaCue at bedside.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2018

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 5, 2018

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

April 16, 2018

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 27, 2018

Completed
Last Updated

May 1, 2018

Status Verified

April 1, 2018

Enrollment Period

1 month

First QC Date

April 16, 2018

Last Update Submit

April 27, 2018

Conditions

Point-of-Care Systems

Outcome Measures

Primary Outcomes (1)

  • hemoglobin levels

    comparing hemoglobin (Hb) levels determined by point of care testing HemaCue and arterial blood gas analyzer with an automated hematology analyzer in critically ill geriatric patients.

    1 months

Study Arms (1)

hb analysis with Hemacue

OTHER

Hb analysis with Hemacue and with arterial blood gas analyser in geriatric ill patients requiring intensive care

Device: HemaCue

Interventions

HemaCueDEVICE

comparing hemoglobin (Hb) levels determined by point of care testing HemaCue and arterial blood gas analyzer with an automated hematology analyzer in critically ill geriatric patients.

Also known as: Blood gas analyser
hb analysis with Hemacue

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • geriatric patients requiring intensive care treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mehtap Honca

Ankara, Kecioren, 06010, Turkey (Türkiye)

Location

Study Officials

  • MEHTAP HONCA, Ass. Prof

    Kecioren training and research Hospital , Department of Anesthesiology and Reanimation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

April 16, 2018

First Posted

April 27, 2018

Study Start

March 1, 2018

Primary Completion

April 1, 2018

Study Completion

April 5, 2018

Last Updated

May 1, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations

TU(1)